CAS: 1217500-55-4; (3-Chloro-2-Fluoropyridin-4-yl)Boronic Acid

该化合物是一种多用途的boronci酸衍生物,在环上有一个氯和氟替代物,该化合物在各种有机合成反应中,特别是在制造复杂的有机分子时,具有更强的回动性和选择性,其独特的电子特性使它成为开发新药和农用化学品的一个有吸引力的构件.

结构式图片

相似化合物

1073353-71-5 1034659-38-5 847664-64-6

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2024239799-A1
    优先权日:2021-04-02
    标 题:(s)-1-(5-((pyridin-3-yl)thio)pyrazin-2-yl)-4'h,6'h-spiro[piperidine-4,5'-pyrrolo [1,2-b]pyrazol]-4'-amine derivatives and similar compounds as shp2 inhibitors for the treatment of e.g. cancer
    发明人:DI FABIO ROMANO; MONTALBETTI CHRISTIAN; PETROCCHI ALESSIA; GRILLO ALESSANDRO; RANDAZZO PIETRO; ROSSETTI ILARIA; CIAMMAICHELLA ALINA
    权利人:C N C C S S C A R L COLLEZIONE NAZ DEI COMPOSTI CHIMICI E CENTRO SCREENING; IRBM S P A
    摘要:The present invention relates to compounds of formula (I). The compounds of the formula (I) are e.g. (S)-1-(5-((pyridin-3-yl)thio) pyrazin-2-yl)-41H,6′H-spiro[piperidine-4,5′-pyrrolo[1,2-b]pyrazol]-41-amine derivatives and similar compounds. The present invention also relates to the compounds of formula (I) for use as Src homology phosphotyrosine phosphatase 2 (SHP2) inhibitors in methods of treatment of e.g. cancer, cardiovascular diseases, immunological disorders, autoimmune disorders, fibrosis, ocular disorders, systemic lupus erythematosus, diabetes, neutropenia, and combinations thereof. The present invention also relates to pharmaceutical compositions containing said compounds and to their methods of synthesis.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1021/jm401808n
    摘要:Fontaine F, Hequet A, Voisin-Chiret AS, Bouillon A, Lesnard A, Cresteil T, Jolivalt C, Rault S. First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump. J Med Chem. 2014 Mar 27;57(6):2536–48. doi: 10.1021/jm401808n.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知